Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 490 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ophthalmic Surgery Clear all

Conditions: Image, Body
Interventions: Optical Coherence Tomography (OCT), Magnetic resonance imaging (MRI); Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Ocular Inflammation
Interventions: 0.5% Loteprednol Etabonate Ophthalmic Ointment, Vehicle of Loteprednol Etabonate Ophthalmic Ointment; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Cataract, Presbyopia
Interventions: Neutral Aspheric Monofocal IOL, Negative Aspheric Monofocal IOL; Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 95 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Cataract
Interventions: Lenstar Biometer; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 50 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Glaucoma, Glaucoma, Open Angle
Interventions: SOLX Titanium Sapphire Laser (TiSaLT), Argon Laser Trabeculoplasty (ALT); Device
Lead sponsor: SOLX, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 5
States / cities: Petaluma, California • Tampa, Florida • New York, New York + 2 more

Conditions: Myopia, Astigmatism, Quality of Lifte
Interventions: Patient Quality of Life andVision after LASIK Surgery; Other
Lead sponsor: Edward E. Manche; Other
Eligibility: 21 Years to 65 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Cataract
Interventions: Phacoemulsification cataract extraction surgery, Small incision cataract surgery; Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 50 Years to 70 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Epiretinal Membrane, Macular Hole, Visually Significant Vitreous Floater, Vitreomacular Traction, Vitreous Hemorrhage, Proliferative Diabetic Retinopathy, Rhegmatogenous Retinal Detachment, Retained Lens Material in the Posterior Segment
Interventions: UNITY Vitreoretinal Cataract System (VCS), CONSTELLATION Vision System, Vitreoretinal ophthalmic surgery; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 8
States / cities: Scottsdale, Arizona • Laguna Hills, California • West Des Moines, Iowa + 5 more

Conditions: Cataract
Interventions: Nepafenac Ophthalmic Suspension, 0.3%, Nepafenac Ophthalmic Suspension, 0.1%, Nepafenac Ophthalmic Suspension 0.3% Vehicle, NEVANAC Vehicle; Drug · Other
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 2,120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Anesthesia Complication
Interventions: Not listed
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Astigmatism
Interventions: Femto arcs, Light Adjustable Lens (LAL); Other · Device
Lead sponsor: Center For Sight; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Venice, Florida • Mt. Pleasant, South Carolina

Conditions: Nuclear Sclerosis of the Lens, Phacoemulsification Cataract Surgery, Cataract Bilateral
Interventions: Cataract extraction with phacoemulsification comparing two systems; Device
Lead sponsor: Nicole Fram M.D.; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cataract
Interventions: Lacrifill Canalicular Filler; Device
Lead sponsor: The Eye Institute of West Florida; Other
Eligibility: 40 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Largo, Florida

Conditions: Corneal Edema After Cataract Surgery
Interventions: Ripasudil, Placebo; Drug
Lead sponsor: Kowa Research Institute, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 44
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Hemet, California + 37 more

Conditions: Retinal Detachment, Proliferative Vitreoretinopathy, Retinoschisis
Interventions: Triamcinolone, Bupivicaine Hydrochloride; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Eye Manifestations
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 0 Years and older
Enrollment: 269 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 2
States / cities: Durham, North Carolina • Cleveland, Ohio

Conditions: Glaucoma
Interventions: VisionBlue; Other
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Glaucoma, Ocular Hypertension
Interventions: Not listed
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pain
Interventions: Vitrase (ovine hyaluronidase) Lyophilized; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Myopia, Astigmatism
Interventions: LASIK with the iFS femtosecond laser; Procedure
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Myopia, Myopic Astigmatism
Interventions: Technolas® TENEO 317 Model 2; Device
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 22 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 10
States / cities: Newport Beach, California • Blaine, Minnesota • Bloomington, Minnesota + 7 more

Conditions: Cataracts
Interventions: Femtosecond Laser; Procedure
Lead sponsor: Innovative Medical; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Goodlettsville, Tennessee

Conditions: Myopia
Interventions: Wavefront-guided LASIK, Wavefront-guided; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 22 Years to 59 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Cataract and IOL Surgery, Cataract Surgery Anesthesia, Cataract Surgery Experience, Nuclear Cataract
Interventions: High IOP Setting, Low IOP Setting; Device
Lead sponsor: Matthew Rauen; Other
Eligibility: 60 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: West Des Moines, Iowa

Search by objective public record fields.

Whole Eye Optical Coherence Tomography (OCT) to Improve Refractive Surgery and Eye Care

Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery

MULTICENTER, DOUBLE-ARM, PATIENT AND ASSESSOR-MASKED, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL TO COMPARE VISUAL PERFORMANCE OF NEGATIVE AND NEUTRAL ASPHERIC MONOFOCAL INTRAOCULAR LENSES

Medications Effect on Lenstar Measurements

SOLX Titanium Sapphire Laser for Trabeculoplasty

Quality of Vision and Quality of Life With LASIK

Phaco Versus Small Incision Cataract Surgery (SICS) Health Economic Study

UNITY VCS Vitreoretinal Surgery

Confirmatory Study Nepafenac 0.3%

Perioperative Complications of Deep Extubation in Adults

Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery

This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal

Lacrifill for Ocular Surface Optimization in Cataract Surgery

A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

Postoperative Pain Control Following Vitreoretinal Surgery

Intraoperative OCT Guidance of Intraocular Surgery

Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness

A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism

Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery

Wavefront-guided vs. Topography-guided LASIK

The Impact of Physiologic Cataract Surgery on Patient Comfort and Medication Usage